PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
28-Apr-2020 Six COVID-19 Patients Treated with RedHill’s Opaganib Under Compassionate Use Show Objective Clinical Improvement RedHill Biopharma
28-Apr-2020 Orgenesis completes acquisition of Tamir Biotechnology, Inc. assets including broad spectrum antiviral platform Orgenesis
28-Apr-2020 Protecting Consumer Safety and Driving Efficiencies with Centralised Label Management NiceLabel
28-Apr-2020 Medical Realities launches a free digital online resource to train 1m healthcare workers for COVID-19 Medical Realities
28-Apr-2020 Restoration of NHS services is about reset not just recovery NHS services
28-Apr-2020 Insilico and Astellas collaborate on AI for a conventionally challenging target family Insilico Medicine
28-Apr-2020 NICE RECOMMENDS STELARA® (USTEKINUMAB) FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS The Janssen Pharmaceutical Companies of Johnson & Johnson
28-Apr-2020 Sareum to Present at BioTrinity 2020 Sareum Holdings plc
28-Apr-2020 MR Solutions now offers the widest range of preclinical nuclear medicine imaging systems of any manufacturer MR Solutions
28-Apr-2020 PHARMIWEB AND TOPRA LAUNCH NEW JOB SHOP pharmiweb
28-Apr-2020 Visbion Image Cubes deployed at NHS Nightingale Hospitals across the UK Vidbion
28-Apr-2020 NICE RECOMMENDS STELARA® (USTEKINUMAB) FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS Janssen
27-Apr-2020 Top-Level industry professionals to speak at Pain Therapeutics Conference in 2 weeks SMi Group
27-Apr-2020 Orgenesis completes acquisition of Tamir Biotechnology, Inc. assets including broad spectrum antiviral platform Orgenesis
27-Apr-2020 Six COVID-19 Patients Treated with RedHill’s Opaganib Under Compassionate Use Show Objective Clinical Improvement RedHill Biopharma
27-Apr-2020 Phase 3 trial of Libtayo® (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival Sanofi
27-Apr-2020 Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients Sanofi
27-Apr-2020 Valo Therapeutics to Support Development of a Pan – Coronavirus Vaccine Valo Therapeutics
27-Apr-2020 Lokelma US label updated to include dosing guidance for the treatment of hyperkalaemia in patients with end-stage renal disease on haemodialysis Label update is based on data from Phase IIIb DIALIZE trial AstraZeneca
27-Apr-2020 Mental health care company COMPASS Pathways concludes successful Series B investment round $80m raised will further the development of psilocybin therapy COMPASS Pathways